Former Chief Executive Officer (3) · PALISADE BIO, INC. (PALI)

Thomas Hallam

A named executive officer of PALISADE BIO in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$533,822

Salary $415,167Stock awards $0

FY2021: $1,394,867

2nd of 4 named executive officers at Palisade BIO by FY2022 total.

4 named officers on file for PALISADE BIO, FY2022

Thomas Hallam’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALISADE BIO’s whole pay program stands against its peers

  • PALISADE BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PALI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 22, 2024 (DEF 14A).

Free

Get Thomas Hallam’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Thomas Hallam compensation by year

PALISADE BIO Summary Compensation Table · all 3 fiscal years held
In US dollars, as PALISADE BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$377,000$453,617$415,167
Bonus$16,563$30,000$0
Stock awards$0$0$0
Option awards$226,100$750,474$96,572
Non-equity incentive$146,111$159,000$0
Pension and deferred compensation$0$0$0
All other$3,261$1,776$22,083
Total$769,035$1,394,867$533,822

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALISADE BIO, INC. DEF 14A filed May 22, 2024, accession 0001493152-24-021034, and prior-year filings.

How this page was built: the PALISADE BIO, INC. filed document, accession 0001493152-24-021034. Every figure is read from that document and cited to the page and table it appears in. Filed May 22, 2024.

$769K
$1.4M
$534K
FY20
FY21
FY22
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option5,122—$2.32
Option267,868—$2.32

Per the Outstanding Equity Awards at Fiscal Year-End table in PALISADE BIO, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

PALISADE BIO’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
J.D FinleyChief Executive Officer and Chief Financial Officer (5)$613,561
Thomas Hallam · this pageFormer Chief Executive Officer (3)$533,822
Robert McRaeChief Operating Officer (15)$500,487
Michael DawsonFormer Chief Medical Officer (13)$189,180

The full PALISADE BIO compensation record

free company brief

This page is one person within PALISADE BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALISADE BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Hallam's compensation dossier · One-time report. No refunds.